Regarding the assessment of aneuploidy stability in luminal B BC patients, it was observed that all patients, irrespective of PR and HER2 status (ER+/PR+/HER2−, ER+/PR−/HER2−, and ER+/PR+/HER2+), exhibited stable aneuploidy. This evidence concerns the gene ERBB2 and breast cancer.